OSPARIX Trademark

Trademark Overview


On Monday, July 16, 2007, a trademark application was filed for OSPARIX with the United States Patent and Trademark Office. The USPTO has given the OSPARIX trademark a serial number of 77230299. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 13, 2015. This trademark is owned by GlaxoSmithKline Biologicals, S.A.. The OSPARIX trademark is filed in the Pharmaceutical Products category with the following description:

HUMAN VACCINES
osparix

General Information


Serial Number77230299
Word MarkOSPARIX
Filing DateMonday, July 16, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 13, 2015
Registration Number3483479
Registration DateTuesday, August 12, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2008

Trademark Statements


Goods and ServicesHUMAN VACCINES

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 13, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals, S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals, S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals, S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Monday, June 8, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 13, 2015CANCELLED SEC. 8 (6-YR)
Friday, June 7, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 7, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 3, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 3, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 12, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, May 27, 2008PUBLISHED FOR OPPOSITION
Wednesday, May 7, 2008NOTICE OF PUBLICATION
Tuesday, April 22, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 21, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 22, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 22, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 20, 2008ASSIGNED TO LIE
Monday, March 10, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 18, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 18, 2007NON-FINAL ACTION E-MAILED
Tuesday, September 18, 2007NON-FINAL ACTION WRITTEN
Monday, September 17, 2007ASSIGNED TO EXAMINER
Friday, July 20, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords


osparix vaccines human